# Neuralink Blindsight Device Receives FDA Breakthrough Device Designation

> fda · REPORTED · 2025-06-01

Neuralink's Blindsight vision-restoration implant received FDA Breakthrough Device Designation in June 2025, accelerating its path toward clinical testing and regulatory approval for blind patients.

- Company: Neuralink
- Sector: neurotech
- Primary source: https://allhealthtech.com/neuralink-update/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.